How does intrahepatic cholestasis of pregnancy usually present?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How Intrahepatic Cholestasis of Pregnancy Usually Presents

ICP typically presents with new-onset pruritus (itching) in the second or third trimester of pregnancy, predominantly affecting the palms and soles, worse at night, and notably WITHOUT a primary rash. 1

Classic Presentation Pattern

Primary Symptom: Pruritus

  • Generalized itching that is most intense on the palms of hands and soles of feet 1
  • Worse at night, significantly disrupting sleep 1
  • No primary rash is present (this is a critical distinguishing feature) 1
  • Excoriations or prurigo nodularis may develop secondary to intense scratching, but these are not the primary presentation 1

Timing of Onset

  • Develops in the late second or third trimester of pregnancy 1, 2
  • Most commonly presents after 28 weeks gestation
  • Incidence ranges from 0.3% to 0.5% in most populations 1

Laboratory Findings

  • Elevated serum bile acids (the diagnostic hallmark) 1
  • Elevated liver transaminases (ALT/AST) in many cases 1
  • May have mild hyperbilirubinemia in some patients 3

Important Clinical Distinctions

What ICP Does NOT Typically Present With:

  • No primary rash (unlike other pregnancy dermatoses) 1
  • No excessive fatigue, malaise, or abdominal pain (if present, consider alternative diagnoses) 1
  • Minimal maternal risk (the mother typically feels well aside from itching) 1

Key Differentiating Features from Other Pregnancy Dermatoses:

The 2021 SMFM guidelines emphasize that pruritus affects approximately 23% of all pregnancies, but ICP is distinguished by:

  • Absence of rash (vs. atopic eruption, polymorphic eruption, pemphigoid gestationis) 1
  • Palm and sole predominance 1
  • Nocturnal worsening 1

Clinical Significance of Presentation

While maternal symptoms are primarily limited to uncomfortable itching, the fetal implications are serious and include 1:

  • Stillbirth risk (increases substantially with bile acids >100 μmol/L)
  • Spontaneous preterm birth
  • Meconium-stained amniotic fluid
  • Fetal respiratory distress

Post-Delivery Resolution

A defining characteristic of ICP is rapid resolution of symptoms after delivery 1, 2. This self-limited nature helps confirm the diagnosis retrospectively and distinguishes it from chronic liver diseases that may present during pregnancy.

Common Pitfall to Avoid

Do not dismiss pruritus in pregnancy as "normal" or attribute it to dry skin without proper evaluation. Any pregnant woman developing new-onset pruritus without a rash in the second half of pregnancy should be evaluated for ICP with serum bile acid and liver transaminase measurements 1. The intensity of itching, particularly when affecting palms and soles and disrupting sleep, should prompt immediate laboratory investigation rather than symptomatic treatment alone.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.